Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effects of Two Fresh Gas Flow Rates During Anesthesia for Lumbar Stabilization Surgery

18 novembre 2026 aggiornato da: Hande Gurbuz

Effects of Different Fresh Gas Flow Rates on Respiratory System Mechanics, Postoperative Pulmonary Complications, Sevoflurane Consumption, and Carbon Footprint in Lumbar Stabilization Surgery in Prone Position: A Prospective Randomized Controlled Trial

This study will compare two fresh gas flow rates during general anesthesia in adults undergoing lumbar stabilization surgery while lying face down. Fresh gas flow is the rate at which oxygen and other gases are supplied to the anesthesia breathing system. Lower flow rates may reduce anesthetic use and its environmental impact, but their effects on breathing during prolonged surgery need further evaluation.

Seventy adults will be randomly assigned to receive a fresh gas flow rate of either 0.3 or 2 liters per minute. Both groups will receive sevoflurane anesthesia and standardized mechanical ventilation.

The main outcome is the percentage change in dynamic respiratory system compliance, a measure of how easily the lungs and chest expand during ventilation, between 10 and 120 minutes after reaching the assigned flow rate. Other assessments will include breathing mechanics, blood oxygen and carbon dioxide levels, brain oxygenation, lung ultrasound findings, postoperative oxygen needs, pulmonary complications, and hospital length of stay. Anesthetic and fresh gas consumption, anesthetic cost, and estimated greenhouse gas emissions will also be compared. Fresh gas flow will be increased if predefined safety criteria are met.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

This single-center trial will be conducted at Bursa City Hospital. Adults aged 18 years or older who are scheduled for elective lumbar stabilization surgery in the prone position will be enrolled. Eligible participants will have an American Society of Anesthesiologists physical status classification of I-III, a body mass index below 40 kg/m², and no known pulmonary disease. Written informed consent will be obtained before enrollment. Participants will be assigned by computer-generated randomization to two parallel groups: minimal fresh gas flow at 0.3 L/min or comparator fresh gas flow at 2 L/min.

Before anesthesia induction, demographic characteristics, comorbidities, smoking status, and hemoglobin levels will be recorded. Lung ultrasound will assess 12 zones, with each zone scored from 0 to 3, yielding a total score of 0-36. Higher scores indicate greater loss of lung aeration.

Automated controlled anesthesia will be used to target an end-tidal sevoflurane concentration corresponding to approximately 1 minimum alveolar concentration, with a bispectral index target of 40-60. Volume-controlled ventilation will be standardized.

High fresh gas flow will initially be used after induction and tracheal intubation. After prone positioning and confirmation of hemodynamic and ventilatory stability, the assigned fresh gas flow rate will be applied. Measurements will be obtained at the following time points:

T1: 5-10 minutes after intubation, while supine during the initial high-flow period.

T2: 10 minutes after reaching the assigned fresh gas flow rate in the prone position.

T3: 30 minutes after reaching the assigned flow rate. T4: 60 minutes after reaching the assigned flow rate. T5: 120 minutes after reaching the assigned flow rate.

Respiratory mechanics, hemodynamic variables, cerebral oxygenation, and arterial blood gas measurements will be recorded at the specified intraoperative time points. Dynamic compliance will be calculated as expired tidal volume divided by the difference between peak inspiratory pressure and positive end-expiratory pressure. Its percentage change will be calculated as [(T5 value - T2 value) / T2 value] × 100. Plateau pressure will be measured using an inspiratory hold. Static compliance, driving pressure, airway resistance, elastance, and mechanical power will also be evaluated. Pulmonary gas exchange assessments will include the PaO2/FiO2 ratio, the alveolar-arterial oxygen gradient, and the arterial-to-end-tidal carbon dioxide difference.

At 30 minutes after surgery in the postanesthesia care unit, lung ultrasound, peripheral oxygen saturation, supplemental oxygen requirements, pain, and early pulmonary complications will be assessed. The change in lung ultrasound score will be calculated as the postoperative score minus the preoperative score. Pulmonary complications during hospitalization and hospital length of stay will also be recorded.

Total sevoflurane and fresh gas consumption will be obtained from the anesthesia workstation. Sevoflurane cost will be calculated using the consumed volume and the unit price determined at the end of the study. Estimated sevoflurane-related carbon dioxide equivalent emissions will be calculated using the protocol-specified conversion factor of approximately 0.198 kg CO2e per milliliter of sevoflurane.

Tipo di studio

Interventistico

Iscrizione (Stimato)

86

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Hande Gurbuz, Prof, MD, PhD
  • Numero di telefono: +90 533 651 56 50
  • Email: handegrbz@gmail.com

Backup dei contatti dello studio

Luoghi di studio

    • Bursa
      • Bursa, Bursa, Turchia (Türkiye), 16110
        • University of Health Sciences, Bursa City Hospital
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Age 18 years or older.
  • Scheduled for elective lumbar stabilization surgery in the prone position.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Body mass index below 40 kg/m².
  • No known pulmonary disease.
  • Willing and able to provide written informed consent.

Exclusion Criteria:

  • ASA physical status IV or higher.
  • Body mass index of 40 kg/m² or higher.
  • Known pulmonary disease.
  • Declining to participate or not providing written informed consent.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Minimal Fresh Gas Flow (0.3 L/min)

Participants will receive a fresh gas flow rate of 0.3 L/min during sevoflurane anesthesia after prone positioning and confirmation of hemodynamic and ventilatory stability. Mechanical ventilation will follow the standardized study protocol. High fresh gas flow will be used if predefined rescue criteria are met.

Fresh gas flow will be reduced to 0.3 L/min after prone positioning and confirmation of hemodynamic and ventilatory stability. Sevoflurane will be administered using automated controlled anesthesia to target approximately 1 minimum alveolar concentration. The assigned flow will be maintained unless predefined rescue criteria require an increase in fresh gas flow.

Comparatore attivo: Fresh Gas Flow (2 L/min)

Participants will receive a fresh gas flow rate of 2 L/min during sevoflurane anesthesia after prone positioning and confirmation of hemodynamic and ventilatory stability. Mechanical ventilation will follow the standardized study protocol. High fresh gas flow will be used if predefined rescue criteria are met.

Fresh gas flow will be set at 2 L/min after prone positioning and confirmation of hemodynamic and ventilatory stability. Sevoflurane will be administered using automated controlled anesthesia to target approximately 1 minimum alveolar concentration. The assigned flow will be maintained unless predefined rescue criteria require an increase in fresh gas flow.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Percentage Change in Dynamic Respiratory System Compliance
Lasso di tempo: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

Dynamic respiratory system compliance (Cdyn), expressed in mL/cmH2O, will be recorded directly from the anesthesia workstation. The percentage change will be calculated as [(Cdyn at T5 - Cdyn at T2) / Cdyn at T2] × 100. T2 is 10 minutes and T5 is 120 minutes after reaching the assigned fresh gas flow rate in the prone position. Negative values indicate a decrease in compliance; higher values indicate better preservation of compliance.

From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Static Respiratory System Compliance
Lasso di tempo: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

Static respiratory system compliance (Cstat) will be calculated as expired tidal volume divided by plateau pressure minus positive end-expiratory pressure and expressed in mL/cmH2O. Plateau pressure will be measured during a 2-second inspiratory hold. The change will be calculated as Cstat at T5 minus Cstat at T2. Negative values indicate a decrease in compliance.

From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Change in Driving Pressure
Lasso di tempo: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

Driving pressure will be calculated as plateau pressure minus positive end-expiratory pressure and expressed in cmH2O. Plateau pressure will be measured during a 2-second inspiratory hold. The change will be calculated as driving pressure at T5 minus driving pressure at T2. Positive values indicate an increase in driving pressure.

From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Change in Airway Resistance
Lasso di tempo: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

Airway resistance will be recorded directly from the anesthesia workstation and expressed in cmH2O·s/L. The change will be calculated as airway resistance at T5 minus airway resistance at T2. Positive values indicate an increase in airway resistance.

From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Change in Mechanical Power
Lasso di tempo: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

Mechanical power during volume-controlled ventilation will be calculated as: 0.098 × tidal volume (L) × respiratory rate (breaths/min) × [peak inspiratory pressure - 0.5 × (plateau pressure - positive end-expiratory pressure)]. Pressures will be expressed in cmH2O and mechanical power in J/min. The change will be calculated as mechanical power at T5 minus mechanical power at T2. Positive values indicate an increase in mechanical power.

From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Change in Respiratory System Elastance
Lasso di tempo: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

Respiratory system elastance will be recorded directly from the anesthesia workstation. The change will be calculated as elastance at T5 minus elastance at T2. Positive values indicate increased respiratory system stiffness.

From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Change in PaO2/FiO2 Ratio
Lasso di tempo: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

The PaO2/FiO2 ratio will be calculated by dividing arterial oxygen partial pressure (PaO2, in mmHg) by the simultaneously recorded inspired oxygen fraction (FiO2, expressed as a decimal). The change will be calculated as the ratio at T5 minus the ratio at T2 and expressed in mmHg. Positive values indicate improved oxygenation.

From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Total Sevoflurane Consumption
Lasso di tempo: From the start of anesthesia to the end of anesthesia on the day of surgery.

Total liquid sevoflurane consumption during anesthesia will be recorded directly from the anesthesia workstation and expressed in milliliters.

From the start of anesthesia to the end of anesthesia on the day of surgery.
Estimated Sevoflurane-Related Carbon Dioxide Equivalent Emissions
Lasso di tempo: From the start of anesthesia to the end of anesthesia on the day of surgery.

Estimated carbon dioxide equivalent (CO2e) emissions associated with sevoflurane consumption will be calculated by multiplying the total liquid sevoflurane volume consumed during anesthesia by the protocol-specified conversion factor of 0.198 kg CO2e per milliliter. Results will be expressed in kilograms of CO2e. This estimate covers sevoflurane-related emissions rather than the total carbon footprint of anesthesia or surgery.

From the start of anesthesia to the end of anesthesia on the day of surgery.
Change in Lung Ultrasound Score
Lasso di tempo: From before anesthesia induction to 30 minutes after surgery in the postanesthesia care unit.

Lung aeration will be assessed using a 12-zone lung ultrasound examination. Each zone will be scored from 0 to 3, yielding a total score of 0-36, with higher scores indicating greater loss of aeration. The change will be calculated as the postoperative score minus the preoperative score. Positive values indicate worsening lung aeration.

From before anesthesia induction to 30 minutes after surgery in the postanesthesia care unit.
Incidence of Postoperative Pulmonary Complications
Lasso di tempo: Postoperative hospitalization, an average of 10 days.

The proportion of participants experiencing at least one postoperative pulmonary complication during hospitalization will be compared between groups. Complications will include atelectasis, pneumonia, respiratory failure, bronchospasm, aspiration pneumonitis, pleural effusion, and pneumothorax. Each participant will be counted once for the overall incidence, regardless of the number of complications. The type of each complication will also be recorded.

Postoperative hospitalization, an average of 10 days.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Investigatore principale: Hande Gurbuz, Prof, MD, PhD, University of Health Sciences, Bursa School of Medicine, Bursa City Hospital

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 novembre 2026

Completamento primario (Stimato)

1 dicembre 2027

Completamento dello studio (Stimato)

1 dicembre 2027

Date di iscrizione allo studio

Primo inviato

12 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

18 novembre 2026

Primo Inserito (Effettivo)

19 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

19 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

18 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • KAEK-2026-18/2
  • 26-AKD-365 (Altro identificatore: Turkish Medicines and Medical Devices Agency (TITCK))

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

There is no plan to share individual participant data with other researchers. Study findings will be reported in aggregate form.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .